1Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, et al. GeneticaUy elevated lipoprotein(a) and increased risk of myocardial infarction [ J ]. JAMA ,2009,301 (22) :2331 - 2339.
2Clarke R,Peden JF,Hopewell JC,et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease[ J]. N Engl J Med ,2009,361 (26) :2518 -2528.
3Thyqesen K,Alpert JS,Jaffe AS,et al. Third universal definition of myocardial infarction [ J ]. Glob Heart,2012,7 (4) :275 - 295.
4Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[ J]. Am J Cardiol, 1983,51 (3) : 606.
5Berg K. A new serum type system in man -the LP system[J]. Ac- ta Pathol Mierobiol Scand, 1963,59:369 - 382.
6Scanu AM, Lawn RM, Berg K. Lipoprotein (a) and atherosclerosis [J]. Ann Intern Med,1991,115(3) :209 -218.
7Malaguarnera M ,Vacante M ,Russo C ,et al. Lipoprotein(a) in car- diovascular diseases[J]. Biomed Res Int,2013,2013:650989.
8Kiechl S,Willeit J. The Mysteries of lipoprotein(a) and cardiovascu- lar disease revisited [ J ]. J Am Coil Cardiol,2010,55 ( 19 ) :2168 - 2170.
9Demant T,Seeberg K, Bedynek A,et al. The metabolism of lipoprotein (a) and other apolipoprotein B - containing lipoproteins: a kinetic study in humans [ J ]. Atherosclerosis ,2001,157 (2) :325 - 339.
10Superko HR. Advanced lipoprotein testing and subfractionation are clinically useful [ J ]. Circulation,2009,119 ( 17 ) :2383 - 2395.
